Together, these results suggested that ZVI@CMC dramatically inhibited the NRF2-mediated cytoprotective programs through restoration of SOX17 protein expression by decreasing expression of DNMTs, which may serve as a potential anticancer strategy against ESCC cells both with and without CCRT resistance. The gene discussed is SOX17; the disease is esophageal squamous cell carcinoma.